Maryland. Prescribing and Dispensing Profile. Research current through November 2015.
|
|
- Teresa Stone
- 6 years ago
- Views:
Transcription
1 Prescribing and Dispensing Profile Maryland Research current through November This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government. 1
2 Schedule II Prescribing Limitations (not related to pain clinics) Schedule II substances may only be dispensed on the written prescription of a practitioner May be dispensed on the oral prescription of a practitioner in an emergency Must be promptly reduced to writing Quantity prescribed and dispensed is limited to an amount sufficient to treat the patient during the emergency period If the prescriber isn t known to the pharmacist, the pharmacist shall make a reasonable effort to determine that the oral authorization came from a registered practitioner, which may include a call back to the prescriber s office at the telephone number listed in the telephone directory or other good faith efforts to insure the practitioner s identity Prescriber shall deliver a written prescription to the pharmacy within seven days May be dispensed on the faxed prescription of a practitioner in the following circumstances: To be compounded for direct administration to a patient by various methods For patients in a long term care facility or hospice program Schedule II prescriptions shall be dispensed within 120 days of being issued Schedule II prescriptions may not be refilled Schedule III, IV and V Prescribing Limitations (not related to pain clinics) Schedule III and IV substances may only be dispensed on the written, faxed, or oral prescription of a practitioner Oral prescriptions must be immediately reduced to writing Schedule V substances may not be distributed or dispensed except for a medical purpose Schedule III V substances shall be dispensed within 120 days of being issued If the prescribing practitioner instructs that the prescription be filled more than 120 days after being issued, a prescription for a controlled substance in Schedule III V shall not be initially filled more than six months after the date it was issued Schedule III V prescriptions cannot be filled or refilled more than six months after originally written or refilled more than five times 2
3 Miscellaneous Prescribing/Dispensing Requirements Practitioners may administer or directly dispense Schedule II V substances Practitioners must submit an application to the appropriate board and pay the appropriate fee in order to dispense prescription drugs Practitioners may not dispense prescription drugs until a written permit is received from the appropriate board Not required in order to dispense starter dosages or free samples Practitioners shall personally prepare and dispense prescription drugs Practitioners shall only dispense prescription drugs to patients of the practitioner only when the patient determines that a pharmacy is not conveniently available to the patient Practitioners shall record the dispensing in the patient s chart Chart shall include a single form which: Indicates that a pharmacy is not conveniently available to the patient States that the determination that a pharmacy is not conveniently available was made solely by the patient Is signed and dated by the patient before dispensing prescription drugs to the patient for the first time Practitioners shall provide the patient with a written prescription Practitioners shall maintain a separate file for Schedule II prescriptions Practitioners shall not make any agreement that denies a patient free choice of pharmacy or pharmacy services Practitioners shall post a conspicuous sign regarding the process for resolving incorrectly filled prescriptions or includes written information regarding the process with each prescription dispensed Practitioners shall prominently display a sign that informs the patient that prescription drugs can be purchased from the permit holder if the patient determines that a pharmacy is not conveniently available Providers may not dispense methadone unless: The authorized provider is associated with a controlled drug therapy program An emergency or medical situation exists under regulations adopted by the department Prescriptions for controlled substances must contain the following: Date and signature of prescriber Full name and address of the patient Drug name, strength, dosage form, quantity prescribed Directions for use Name, address, and registration number of prescriber Prescribing/Dispensing Limitations for Dentists No separate statutes or regulations related to prescribing and dispensing limitations for dentists. 3
4 Prescribing/Dispensing Limitations for Optometrists A therapeutically certified optometrist may administer and prescribe topical therapeutic pharmaceutical agents limited to: Ocular antihistamines, decongestants, and combinations thereof Ocular antiallergy pharmaceutical agents Ocular antibiotics and combinations of ocular antibiotics, excluding specially formulated or fortified antibiotics Anti-inflammatory agents Ocular lubricants and artificial tears Tropicamide Homatropine A therapeutically certified optometrist may administer or prescribe topical steroids in accordance with practice protocols established by the board A therapeutically certified optometrist may not administer or prescribe: Antiviral agents Antifungal agents Antimetabolite agents Antiparasitic agents Pain Clinic/Pain Management Regulations No specific statutes or regulations identified. Training or Education Requirements or Recommendations for Practitioners who Prescribe or Dispense Controlled Substances No specific statutes or regulations identified. 4
5 Medical Marijuana or Controlled Substances Therapeutic Research Program Provisions This section deals only with the conditions that qualify a patient for the use of medical marijuana or a therapeutic research program and the attendant physician responsibilities. For complete information on state medical marijuana and therapeutic research programs, please visit the NAMSDL website at A certifying physician is an individual who is licensed by the board of medicine in Maryland and who is approved by the Commission to make marijuana available to patients for medical use Written certification is issued by a certifying physician to a qualified patient with whom s/he has a bona fide physician-patient relationship Includes a written statement certifying that, in the physician s professional opinion, after having completed a full assessment of the patient s medical history and current medical condition, the patient has a condition: That meets the inclusion criteria and does not meet the exclusion criteria of the certifying physician s application For which the benefits of the medical use of marijuana would likely outweigh the health risks for the patient A physician may determine that a patient qualifies for a written certification only: If the qualifying patient has registered with the Commission For whom the physician has a bona fide physician-patient relationship If the qualifying patient meets the physician s inclusion criteria If the qualifying patient does not meet the inclusion criteria and the physician has determined that the potential benefits of the medical use of cannabis likely outweigh the health risks for the patient Certifying physician shall log on to the Commission website to transmit the certification to the Commission and, if requested, provide a copy of the written certification to the patient A written certification shall include: Physician s name, Maryland Board of Physicians license number, and office telephone number Qualifying patient s name, date of birth, address, and county of residence Medical condition requiring cannabis The date of qualification as a qualifying patient May contain a statement certifying that, in the physician s professional opinion, a 30-day supply of medical cannabis would be inadequate to meet the medical needs of the patient Certifying physician may discuss the medical use of cannabis with the patient A certifying physician shall terminate a written certification if: The qualifying patient meets the physician s exclusion criteria Treatment with medical cannabis is no longer necessary for the patient Adverse effects of medical cannabis outweigh the benefits to the patient s health There is evidence that the patient engaged in diversion of medical cannabis Physician may terminate a written certification if the patient shows any signs of substance abuse Certifying physician shall notify the Commission within one business day of termination 5
6 Medical Marijuana or Controlled Substances Therapeutic Research Program Provisions, cont d. Qualifying patient shall only have one certifying physician at a time Qualifying patient may seek renewal of a written certification not less than 30 calendar days after it was issued by notifying the patient s certifying physician Physician may renew certification only if it is determined that the patient still meets the criteria Physician shall notify Commission upon renewing a certification Physician may not renew a certification unless the physician has made a full, in-person assessment of the patient within the 365 days before the reissuance A physician seeking registration as a certifying physician shall submit an application to the Commission that includes the following: The physician s full name, SSN, office addresses and phone numbers, current address, MD Board of Physicians license number, and plan to assess patient outcomes, provide follow-up care, and to collect and analyze data An attestation that: Physician s license is in good standing, the physician is registered to prescribe controlled substances, and a standard patient evaluation will be completed and include: A history, physical examination, review of symptoms, and any other pertinent medical information The medical conditions for which the physician may issue written certifications The physician s other inclusion criteria The reasons the physician may deny issuing a written certification To be approved as a certifying physician, a physician shall submit a proposal to the Commission that includes: The reasons for including a patient under the care of the physician for the purposes of medical use of marijuana, including the patient s qualifying medical conditions The reasons the physician will use to exclude patients from the care of the physician The physician s plan for screening a patient for dependence, both before and after the qualifying patient is issued a written certification The physician s plan for the ongoing assessment and follow-up care of a patient and for collecting and analyzing data Commission encourages physicians to apply to register as a certifying physician to treat patients with the following medical conditions: A chronic or debilitating disease or medical condition that results in a patient being admitted into hospice or receiving palliative care A chronic or debilitating disease or medical condition or the treatment of a chronic or debilitating disease or medical condition that produces: cachexia, anorexia, or wasting syndrome; severe pain; severe nausea; seizures; severe or persistent muscle spasms; severe conditions for which other treatments are ineffective Glaucoma or PTSD 6
7 Medical Marijuana or Controlled Substances Therapeutic Research Program Provisions, cont d. A physician may be registered as a certifying physician to treat a patient who has a condition that is: Severe For which other medical treatments have been ineffective If the symptoms can reasonably be expected to be relieved by the use of medical cannabis Applications are deemed approved unless the Commission notifies the applicant that the application has been denied Approvals are valid for two years Certifying physician shall apply to renew a registration to certify at the time of renewal of the physician s license to practice medicine Commission shall provide physician with notice of renewal 90 days before expiration of the registration Commission shall grant a renewal if: The physician attests that the physician s license to practice is in good standing and the physician s registration by the State to prescribe controlled substances is valid The physician has otherwise complied with the regulations Physician or spouse of certifying physician may not receive any compensation, including promotion, recommendation, advertising, subsidized rent, or anything of value from a licensed grower, licensed processor, or a licensed dispensary unless the certifying physician submits unless the physician submits an application to the Commission for approval for the compensation The application shall disclose: The specific type of compensation and specific amount or value of compensation and the services for which the compensation will be paid An attestation that the compensation does not violate the Maryland Medical Practice Act or patient referral laws Commission shall deny an application for compensation if: The compensation is based on any agreement or arrangement for the certifying physician to refer, direct, or recommend qualifying patients to the licensed grower, licensed processor, or licensed dispensary to obtain medical cannabis The physician refuses to attest that the compensation would not violate the Medical Practice Act or patient referral laws The compensation would violate the Medical Practice Act or patient referral laws Commission may deny an application if the compensation agreement may create an appearance that the compensation compromises the independent judgment of the certifying physician in the treatment of a patient If the application is denied, the physician shall be notified in writing and shall be entitled to a hearing to review the denial Each certifying physician shall submit an annual report to the Commission that includes: The number of patients served The county of residence of each patient Any medical condition for which medical marijuana was recommended A summary of clinical outcomes, including adverse events and any cases of suspected diversion 7
8 Medical Marijuana or Controlled Substances Therapeutic Research Program Provisions, cont d. A licensed dispensary may appoint an individual who is a Maryland physician, nurse practitioner, or pharmacist to function as clinical director Physicians shall not be subject to arrest, prosecution, or any civil or administrative penalty, including a civil penalty or disciplinary action by a licensing board, or be denied any right or privilege for medical marijuana PMP Requirements for Mandatory Registration and Access No specific statutes or regulations identified. Patient Referral to Treatment No specific statutes or regulations identified. Board Guidelines None. 8
Alabama. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Alabama Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
WHAT YOU SHOULD KNOW PATIENTS, PHYSICIANS AND CAREGIVERS
WHAT YOU SHOULD KNOW PATIENTS, PHYSICIANS AND CAREGIVERS Information and Checklists What You Should Know provides a summary of program requirements of the New Jersey Medicinal Marijuana Program (NJMMP).
247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES
TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER c: LONG-TERM CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION 300.1610 MEDICATION POLICIES
SB 420 Medical Marijuana Identification Card MMIC Program
SB 420 Medical Marijuana Identification Card (MMIC) Program Nevada County Sacramento Public Health Department Medical Marijuana Program Unit MMIC Program Office of County Health Services 500 Crown Point
Senate File Introduced
Senate File - Introduced SENATE FILE BY BOLKCOM A BILL FOR An Act relating to the creation of a medical marijuana Act including the creation of nonprofit dispensaries, and providing for civil and criminal
Prescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
Frequently Asked Questions
1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation
SAN MATEO COUNTY HEALTH SYSTEM Medical Marijuana Identification Card Program
SAN MATEO COUNTY HEALTH SYSTEM Medical Marijuana Identification Card Program 225-37 th Avenue San Mateo, CA 94403 Telephone 650.573.2395 Fax 650.573.2576 http://www.smhealth.org INSTRUCTIONS - PATIENT
MARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland
MARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland 21215 www.mbp.state.md.us E-mail: mdh.mbppadispense@maryland.gov : ADDENDUM FOR PHYSICIAN ASSISTANT (PA) TO DISPENSE PRESCRIPTION DRUGS INSTRUCTIONS
Prescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
MICHIGAN MEDICAL MARIHUANA ACT Initiated Law 1 of The People of the State of Michigan enact:
MICHIGAN MEDICAL MARIHUANA ACT Initiated Law 1 of 2008 AN INITIATION of Legislation to allow under state law the medical use of marihuana; to provide protections for the medical use of marihuana; to provide
Interim Commissioner Lauren A. Smith and Members of the Public Health Council
DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JOHN W. POLANOWICZ SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER The Commonwealth of Massachusetts Executive Office of Health and
Prescription Monitoring Programs - Legislative Trends and Model Law Revision
Prescription Drug Monitoring Programs Training and Technical Assistance Center Webinar Series National Alliance for Model State Drug Laws: Legislative Round-Up July 22, 2015 Prescription Monitoring Programs
Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements
6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services
PRESCRIPTION MONITORING PROGRAM STATE PROFILES MASSACHUSETTS
PRESCRIPTION MONITORING PROGRAM STATE PROFILES MASSACHUSETTS Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
Instructions for Applying for a RENEWAL Medical Marihuana Registry Identification Card for a MINOR PATIENT
DCH/MMP-504 (Rev. 3/10) Instructions for Applying for a RENEWAL Medical Marihuana Registry Identification Card for a MINOR PATIENT To renew your ID card as a minor (under 18 years old), you must complete
Medical Marijuana Laws and Regulations for Patients, Caregivers and Physicians: Maine, New Jersey, Rhode Island, and Vermont
Medical Marijuana Laws and Regulations for Patients, s and Physicians: Maine, New Jersey, Rhode Island, and Vermont This chart is intended for educational purposes only; you should not act or rely upon
COLORADO MEDICAL BOARD RULES
RULE 800 3 CCR 713-30 RULES REGARDING THE DELEGATION AND SUPERVISION OF MEDICAL SERVICES TO UNLICENSED PERSONS PURSUANT TO SECTION 12-36-106(3)(l), C.R.S. INTRODUCTION Basis. The general authority for
OKLAHOMA ADMINISTRATIVE CODE TITLE 435. STATE BOARD OF MEDICAL LICENSURE AND SUPERVISION CHAPTER 15. PHYSICIAN ASSISTANTS INDEX
Updated September 1, 2016 OKLAHOMA ADMINISTRATIVE CODE TITLE 435. STATE BOARD OF MEDICAL LICENSURE AND SUPERVISION CHAPTER 15. PHYSICIAN ASSISTANTS INDEX Subchapter 1. General Provisions Subchapter 3.
SENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED APRIL, 0 Sponsored by: Senator LORETTA WEINBERG District (Bergen) Senator JOSEPH F. VITALE District (Middlesex) Senator JAMES W. HOLZAPFEL District
NEW MEXICO PRACTITIONER S MANUAL
NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us
The Wisconsin epdmp:
The Wisconsin epdmp: Frequently Asked Questions Pursuant to 2015 Wisconsin Act 266, effective April 1, 2017, Wisconsin-licensed physicians and other prescribers must review a patient s records from Wisconsin
PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE
PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
Prescription Monitoring Program State Profiles - Michigan
Prescription Monitoring Program State Profiles - Michigan Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
Prescription Monitoring Program State Profiles - Texas
Prescription Monitoring Program State Profiles - Texas Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION
RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION CHAPTER 0800-02-25 WORKERS COMPENSATION MEDICAL TREATMENT TABLE OF CONTENTS 0800-02-25-.01 Purpose and Scope
Payment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:
Your Rx Pharmacy Notice of our privacy practices THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
> TITLE 13. LAW AND PUBLIC SAFETY
N.J.A.C. 13:45J-1.1 13:45J-1.1 Purpose The rules in this chapter regulate the receipt and acceptance by prescribers of anything of value from pharmaceutical manufacturers to ensure that such relationships
SHASTA COUNTY HEALTH & HUMAN SERVICES AGENCY MEDICAL MARIJUANA PROGRAM APPLICATION/RENEWAL INSTRUCTIONS
SHASTA COUNTY HEALTH & HUMAN SERVICES AGENCY MEDICAL MARIJUANA PROGRAM APPLICATION/RENEWAL INSTRUCTIONS Who may apply? The MMIC program is voluntary. Any resident of Shasta County whose physician recommends
This continuing education offering is written specifically for pharmacists and pharmacy technicians in New Jersey.
Select CE This continuing education offering is written specifically for pharmacists and pharmacy technicians in New Jersey. Select CE is accredited by the Accreditation Council for Pharmacy Education
Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing
Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing 700.001: Definitions Delegate means an authorized support staff
ALABAMA~STATUTE. Code of Alabama et seq. DATE Enacted Alabama Board of Medical Examiners
ALABAMA~STATUTE STATUTE Code of Alabama 34-24-290 et seq DATE Enacted 1971 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED PAs PER PHYSICIAN APPLICATION QUALIFICATIONS
Frequently Asked Questions
Frequently Asked Questions This FAQ is as complete as possible, however it is not possible to answer every question, and some categories overlap. Because of this, some questions/answers may be in a different
Prescriptive Authority Agreement Advanced Practice Registered Nurses, and Physician Assistants
Prescriptive Authority Agreement Advanced Practice Registered Nurses, and Physician Assistants I. Purpose This Prescriptive Authority Agreement (referred to as PAA, agreement or document ) authorizes the
Post-Test/ Evaluation
/ Evaluation Outcomes Personal Pharmacist Training Program To obtain ACPE credit, select the electronic /Evaluation link from the training program Main Menu. Completion of this manual test does not award
Table of Contents. Introduction: Basis, purpose and statutory provision
RULE 800 COLORADO BOARD OF MEDICAL EXAMINERS RULES REGARDING THE DELEGATION AND SUPERVISION OF MEDICAL SERVICES TO UNLICENSED HEALTH CARE PROVIDERS PURSUANT TO SECTION 12-36-106(3)(l), C.R.S. Table of
NOTICE OF EXEMPT RULEMAKING TITLE 9. HEALTH SERVICES CHAPTER 17. DEPARTMENT OF HEALTH SERVICES MEDICAL MARIJUANA PROGRAM PREAMBLE
NOTICE OF EXEMPT RULEMAKING TITLE 9. HEALTH SERVICES CHAPTER 17. DEPARTMENT OF HEALTH SERVICES MEDICAL MARIJUANA PROGRAM PREAMBLE 1. Sections affected Rulemaking Action Chapter 17 New Chapter Article 1
WEST PENN ALLEGHENY HEALTH SYSTEM
WEST PENN ALLEGHENY HEALTH SYSTEM Policy Name: Vendor Conduct Policy Page 1 of 8 Original Date: June 9, 2009 Reviewed by: Kathy DeLacio Date of Review: Date of Revision: May 21, 2013 Revision: 2 Document
Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections
Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 0 S SENATE BILL 0* Health Care Committee Substitute Adopted /1/ Short Title: Health-Local Confinement/Vet. Controlled Sub. (Public) Sponsors: Referred to: May,
ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE
Medical Examiners Chapter 540-X-18 ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-18 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) FOR CERTIFIED REGISTERED
RULE DELEGATION AND SUPERVISION OF MEDICAL SERVICES TO UNLICENSED HEALTH CARE PROVIDERS PURSUANT TO SECTION (3)(l), C.R.S.
DEPARTMENT OF REGULATORY AGENCIES Colorado Medical Board RULE 800 - DELEGATION AND SUPERVISION OF MEDICAL SERVICES TO UNLICENSED HEALTH CARE PROVIDERS PURSUANT TO SECTION 12-36-106(3)(l), C.R.S. 3 CCR
RULES OF DEPARTMENT OF HEALTH DIVISION OF PAIN MANAGEMENT CLINICS CHAPTER PAIN MANAGEMENT CLINICS TABLE OF CONTENTS
RULES OF DEPARTMENT OF HEALTH DIVISION OF PAIN MANAGEMENT CLINICS CHAPTER 1200-34-01 PAIN MANAGEMENT CLINICS TABLE OF CONTENTS 1200-34-01-.01 Definitions 1200-34-01-.11 Training Requirements 1200-34-01-.02
Florida s New Law on Controlled Substance Prescribing
FLORIDA MEDICAL ASSOCIATION Florida s New Law on Controlled Substance Prescribing HB 21, signed into law by Gov. Rick Scott on March 19, 2018, imposes a number of legal requirements on healthcare practitioners
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
Nursing Chapter 610-X-5 ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05
(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.
ACTION: Revised DATE: 07/20/2017 4:25 PM 4729-5-30 Manner of issuance of a prescription. (A) A prescription, to be valid, must be issued for a legitimate medical purpose by an individual prescriber acting
NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
Definitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
Prescribing Standards for Nurse Practitioners (NPs)
Standards Prescribing Standards for Nurse Practitioners (NPs) Month Year PRESCRIBING FOR NURSE PRACTITIONERS MONTH YEAR i Approved by the College and Association of Registered Nurses of Alberta () Provincial
McMinnville School District #40
McMinnville School District #40 Code: JHCD/JHCDA-AR Adopted: 1/08 Revised/Readopted: 8/10; 2/14; 2/15 Orig. Code: JHCD/JHCDA-AR Prescription/Nonprescription Medication Students may, subject to the provisions
District of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
SENATE APPROPRIATIONS COMMITTEE FISCAL NOTE
BILL NO. Senate Bill 3 PRINTER NO. 840 AMOUNT FUND $1.3 Million FY 2015-16 Professional Licensure Augmentation Account (BPOA Start-Up) DATE INTRODUCED January 26, 2015 PRIME SPONSOR Senator Folmer DESCRIPTION
Medical Marijuana - Act 16 of 2016
Medical Marijuana - Act 16 of 2016 Act 16 of 2016 creates a stand-alone act entitled the Medical Marijuana Act and establishes a program for the use of medical marijuana (MM) to be administered by the
COLORADO MEDICAL BOARD RULES
RULE 800 3 CCR 713-30 RULES REGARDING THE DELEGATION AND SUPERVISION OF MEDICAL SERVICES TO UNLICENSED PERSONSHEALTH CARE PROVIDERS PURSUANT TO SECTION 12-36-106(3)(l), C.R.S. Table of Contents Introduction:
PATIENTS (Under the New Law Registered Cardholders):
There are important changes to the Montana Medical Marijuana Program that will affect you. These frequently asked questions (FAQs) will provide answers to questions about the new law and the transition
AN ACT. Be it enacted by the General Assembly of the State of Ohio:
(131st General Assembly) (Substitute House Bill Number 124) AN ACT To amend section 4729.01 and to enact sections 4723.4810, 4729.282, 4730.432, and 4731.93 of the Revised Code regarding the authority
ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-19 PAIN MANAGEMENT SEVICES TABLE OF CONTENTS
Medical Examiners Chapter 540-X-19 ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-19 PAIN MANAGEMENT SEVICES TABLE OF CONTENTS 540-X-19-.01 540-X-19-.02 540-X-19-.03 540-X-19-.04
ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS
Medical Examiners Chapter 540-X-8 ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS 540-X-8-.01 540-X-8-.02 540-X-8-.03
Form CMS (5/2017) Page 1
Use this pathway for a resident who has pain symptoms or can reasonably be expected to experience pain (i.e., during therapy) to determine whether the facility has provided and the resident has received
Licensed Pharmacy Technicians Scope of Practice
Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
H 7297 S T A T E O F R H O D E I S L A N D
LC001 01 -- H S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO HEALTH AND SAFETY- LILA MANFIELD SAPINSLEY COMPASSIONATE CARE ACT Introduced By: Representatives
a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.
Board of Pharmacy Administrative Rules Version 12 January 18, 2013 Part 19 Remote Pharmacies 19.1 General Purpose: (a) This Part is enacted pursuant to 26 V.S.A. 2032 which initially authorized the Board
Physician Assistant Jurisprudence Examination
Physician ssistant Jurisprudence xamination The examination you take will be composed of 50 questions, randomly selected from the questions listed below. You will have 90 minutes to take the exam. For
Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans
Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans Jill Strykowski and Michelle Aytay MPhA Public Affairs Co Chairs, PPAJTF Session Objectives Outline the outcomes from the 2016 Legislative
MEDICAL LICENSURE COMMISSION OF ALABAMA ADMINISTRATIVE CODE CHAPTER 545 X 6 THE PRACTICE OF MEDICINE OR OSTEOPATHY ACROSS STATE LINES
Medical Licensure Chapter 545 X 6 MEDICAL LICENSURE COMMISSION OF ALABAMA ADMINISTRATIVE CODE CHAPTER 545 X 6 THE PRACTICE OF MEDICINE OR OSTEOPATHY ACROSS STATE LINES TABLE OF CONTENTS 545 X 6.01 545
Chapter 52. Board of Pharmacy.
Chapter 52. Board of Pharmacy. (Words in boldface and underlined indicate language being added; words [CAPITALIZED AND BRACKETED] indicate language being deleted. Complete new sections are not in boldface
Prescription Monitoring Program State Profiles - Pennsylvania
Prescription Monitoring Program State Profiles - Pennsylvania Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
Prescription Monitoring Program State Profiles - Kentucky
Prescription Monitoring Program State Profiles - Kentucky Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
Title 22: HEALTH AND WELFARE
Title 22: HEALTH AND WELFARE Chapter 558-C: MAINE MEDICAL USE OF MARIJUANA ACT Table of Contents Subtitle 2. HEALTH... Part 5. FOODS AND DRUGS... Section 2421. SHORT TITLE... 3 Section 2422. DEFINITIONS...
EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: March 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
The CMS State Operations Manual Overview and Changes
The CMS State Operations Manual Overview and Changes Omnicare, Inc. Page 1 Overview of the CMS State Operations Manual Executive Summary Historical Perspective The Requirements Pharmacy Services Labeling
New Jersey issues rules to chill drug manufacturer payments to prescribers
New Jersey issues rules to chill drug manufacturer payments to prescribers January 10, 2018 The New Jersey Attorney General plans to finalize new limits on payments and other benefits that New Jersey licensed
Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists
Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince
10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
DRAFT FOR INFORMAL COMMENT
DRAFT FOR INFORMAL COMMENT Please send comments to the Office of Medical Cannabis at health.cannabis.regs@state.mn.us Draft Rules for Medical Cannabis Registry: Patient Enrollment and Health Care Practitioners
INFORMATION ABOUT YOUR OXFORD COVERAGE REIMBURSEMENT PART I OXFORD HEALTH PLANS OXFORD HEALTH PLANS (NJ), INC.
OXFORD HEALTH PLANS (NJ), INC. INFORMATION ABOUT YOUR OXFORD COVERAGE PART I REIMBURSEMENT Overview of Provider Reimbursement Methodologies Generally, Oxford pays Network Providers on a fee-for-service
78th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill 2028 SUMMARY
Sponsored by COMMITTEE ON HEALTH CARE th OREGON LEGISLATIVE ASSEMBLY-- Regular Session House Bill SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body
The Alberta Pharmacists Practice Model, Implications for Hospital Pharmacists. October 2014
The Alberta Pharmacists Practice Model, Implications for Hospital Pharmacists October 2014 Disclosure I have no real or potential conflict to disclose Learning Objectives Understand the principles in which
UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
Gilead Sciences, Inc. GS-US-248-0123, Amendment 1, 19-JUN-2012 A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with
NEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)
Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory) By: Katie Blair, PharmD, RPh Author Disclosure: Katie Blair and Elite Professional Education, LLC do not have any actual or potential
IC Chapter 19. Regulation of Pharmacy Technicians
IC 25-26-19 Chapter 19. Regulation of Pharmacy Technicians IC 25-26-19-1 "Board" Sec. 1. As used in this chapter, "board" refers to the Indiana board of pharmacy established by IC 25-26-13-3. IC 25-26-19-2
YALE-NEW HAVEN HOSPITAL MEDICAL STAFF POLICY & PROCEDURE CONFLICT OF INTEREST
YALE-NEW HAVEN HOSPITAL MEDICAL STAFF POLICY & PROCEDURE CONFLICT OF INTEREST Definitions External financial interests can create conflicts when they provide an incentive to a Medical Staff member to affect
DISPENSING BY REGISTERED NURSES
1999 DISPENSING BY REGISTERED NURSES This Interpretive Document was approved by ARNNL Council in 1999. Dispensing By Registered Nurses Dispensing is a practice of pharmacy in the province of Newfoundland
The District of Columbia Death with Dignity Act (Patient Request for Medical Aid-in-Dying)
Office of Origin: I. PURPOSE II. A. authorizes medical aid in dying and allows an adult patient with capacity, who has been diagnosed with a terminal disease with a life expectancy of six months or less,
2. Short term prescription medication and drugs (administered for less than two weeks):
Medication Administration Procedure This is a companion document with Policy # 516 Student Medication To access the policy: click on Policies (under the District Information heading) The Licensed School
Last updated on April 23, 2017 by Chris Krummey - Managing Attorney-Transactions
Physician Assistant Supervision Agreement Instructions Sheet Outlined in this document the instructions for completing the Physician Assistant Supervision Agreement and forming a supervision agreement
Referred to Committee on Health and Human Services. SUMMARY Provides for schools to obtain and administer autoinjectable epinephrine.
S.B. SENATE BILL NO. COMMITTEE ON HEALTH AND HUMAN SERVICES MARCH, 0 Referred to Committee on Health and Human Services SUMMARY Provides for schools to obtain and administer autoinjectable epinephrine.
(b) Is administered via a transdermal route; or
ACTION: To Be Refiled DATE: 10/10/2018 2:31 PM 4723-9-10 Formulary; standards of prescribing for advanced practice registered nurses designated as clinical nurse specialists, certified nurse-midwives,
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of
Prescriptive Authority for Pharmacists. Frequently Asked Questions for Pharmacists
Prescriptive Authority for Pharmacists Frequently Asked Questions for Pharmacists Disclaimer: When in doubt, the text of the official bylaws should be consulted. They are available at: http://napra.ca/content_files/files/saskatchewan/proposedprescribingbylawsawaitingtheministerofhealt
Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information
SECOND SESSION THIRTY-NINTH LEGISLATURE Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information Introduced 29 February 2012 Passed in principle 29 May 2012 Passed 15 June
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
NEW STANDARD OF PRACTICE PRESCRIBING
NEW STANDARD OF PRACTICE PRESCRIBING Notice to College Members June 21, 2018 Following consultation with College Members, on June 16, 2018 Council of the College approved a new Standard of Practice on
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015 Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related
What Would You Do? Scenarios In Pharmacy Law
What Would You Do? Scenarios In Pharmacy Law Kathryn Schultz, PharmD, BCPS, BCOP Scott A. Meyers, RPh, MS, FASHP Jim Owen, Legislative Consultant Disclosures Kathryn Schultz has no conflicts to disclose.
The California End of Life Option Act (Patient s Request for Medical Aid-in-Dying)
Office of Origin: I. PURPOSE II. III. A. The California authorizes medical aid in dying and allows an adult patient with capacity, who has been diagnosed with a terminal disease with a life expectancy
THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT
PRINTER'S NO. THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL No. INTRODUCED BY LEACH AND FERLO, JUNE, REFERRED TO JUDICIARY, JUNE, Session of AN ACT 1 1 1 1 Amending Title (Decedents, Estates and Fiduciaries)